Amanda M. Kong

1.3k total citations
51 papers, 837 citations indexed

About

Amanda M. Kong is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Amanda M. Kong has authored 51 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 15 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Amanda M. Kong's work include Respiratory viral infections research (9 papers), Neonatal Respiratory Health Research (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Amanda M. Kong is often cited by papers focused on Respiratory viral infections research (9 papers), Neonatal Respiratory Health Research (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Amanda M. Kong collaborates with scholars based in United States, France and United Kingdom. Amanda M. Kong's co-authors include Karina Raimundo, Ashley L. Cole, Aryeh Fischer, Jeffrey J. Swigris, Tilman Koelsch, Sally W. Wade, Evans R. Fernández Pérez, Amy L. Olson, Joshua J. Solomon and Kathryn Anastos and has published in prestigious journals such as Blood, Scientific Reports and CHEST Journal.

In The Last Decade

Amanda M. Kong

47 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda M. Kong United States 15 422 254 166 147 143 51 837
Sedat Altın Türkiye 19 633 1.5× 207 0.8× 181 1.1× 191 1.3× 70 0.5× 104 1.2k
Nurdan Köktürk Türkiye 20 723 1.7× 205 0.8× 92 0.6× 295 2.0× 60 0.4× 99 1.1k
Michael F. Tenholder United States 18 368 0.9× 166 0.7× 126 0.8× 161 1.1× 76 0.5× 43 838
Kathleen L. Horan United States 7 158 0.4× 205 0.8× 136 0.8× 71 0.5× 105 0.7× 8 622
Jette Brommann Kornum Denmark 11 275 0.7× 468 1.8× 171 1.0× 72 0.5× 66 0.5× 20 958
Irit Krause Israel 18 157 0.4× 320 1.3× 203 1.2× 45 0.3× 93 0.7× 78 1.2k
Valérie Patenaude Canada 17 373 0.9× 294 1.2× 46 0.3× 228 1.6× 133 0.9× 31 1.4k
Mira T. Keddis United States 17 363 0.9× 147 0.6× 84 0.5× 48 0.3× 142 1.0× 58 982
S. J. Carlan United States 18 190 0.5× 310 1.2× 92 0.6× 40 0.3× 424 3.0× 138 1.2k
Seok Jeong Lee South Korea 16 463 1.1× 127 0.5× 79 0.5× 107 0.7× 23 0.2× 63 830

Countries citing papers authored by Amanda M. Kong

Since Specialization
Citations

This map shows the geographic impact of Amanda M. Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda M. Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda M. Kong more than expected).

Fields of papers citing papers by Amanda M. Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda M. Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda M. Kong. The network helps show where Amanda M. Kong may publish in the future.

Co-authorship network of co-authors of Amanda M. Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda M. Kong. A scholar is included among the top collaborators of Amanda M. Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda M. Kong. Amanda M. Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Amanda M., Shamim Khan, J. Isabelle Choi, et al.. (2025). Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2. Journal of Comparative Effectiveness Research. 14(11). e250026–e250026.
2.
Berry, Mark, Amanda M. Kong, Roger Paredes, et al.. (2025). Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19. Scientific Reports. 15(1). 27441–27441. 1 indexed citations
3.
4.
Le, Tina, et al.. (2023). Tips to Quit Smoking: Perspectives from Vietnamese Healthcare Providers, Community Leaders, and Past Tobacco Users in the United States. International Journal of Environmental Research and Public Health. 20(12). 6160–6160. 1 indexed citations
5.
Kong, Amanda M., et al.. (2021). Diagnostic Testing of Vaginitis: Improving the Value of Care. Population Health Management. 24(4). 515–524. 13 indexed citations
6.
Kong, Amanda M., et al.. (2021). Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data. American Journal of Perinatology. 40(14). 1529–1536. 9 indexed citations
7.
Best, Jennie H., Shalini Mohan, Amanda M. Kong, et al.. (2020). Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study. Advances in Therapy. 37(12). 4981–4995. 11 indexed citations
8.
Kong, Derek Kai, et al.. (2020). Ambulatory tonsillectomy for children with severe obstructive sleep apnea without risk factors. American Journal of Otolaryngology. 41(4). 102467–102467. 6 indexed citations
9.
Kong, Amanda M., Alexis Pozen, Kathryn Anastos, Elizabeth A. Kelvin, & Denis Nash. (2019). Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis. AIDS Patient Care and STDs. 33(3). 93–103. 73 indexed citations
10.
Waickman, Adam T., Heather Friberg, Amanda M. Kong, et al.. (2019). Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003. Frontiers in Immunology. 10. 1778–1778. 27 indexed citations
11.
Subramaniam, Deepa S., Melissa Pavilack, Hairong Huo, et al.. (2019). P2.16-37 Impact of Brain Metastases on Healthcare Utilisation and Costs in Patients with NSCLC Treated with EGFR-TKIs. Journal of Thoracic Oncology. 14(10). S880–S880.
12.
Best, Jennie H., Amanda M. Kong, David M. Smith, Ibrahim M. Abbass, & Margaret Michalska. (2019). <p>Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis</p>. ClinicoEconomics and Outcomes Research. Volume 11. 799–807. 7 indexed citations
13.
14.
Kong, Amanda M., Gilwan Kim, Margaret Michalska, & Jennie H. Best. (2018). Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States. Rheumatology and Therapy. 5(1). 159–170. 5 indexed citations
15.
Kong, Amanda M., et al.. (2018). Healthcare Cost of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis. Value in Health. 21. S251–S251. 1 indexed citations
16.
Paramore, Clark, et al.. (2018). Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence. Blood. 132(Supplement 1). 4811–4811. 1 indexed citations
17.
18.
Fischer, Aryeh, Amanda M. Kong, Jeffrey J. Swigris, Ashley L. Cole, & Karina Raimundo. (2017). All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement. The Journal of Rheumatology. 45(2). 235–241. 33 indexed citations
19.
Kong, Amanda M., et al.. (2017). A Retrospective, Longitudinal, Claims-Based Comparison of Concomitant Diagnoses Between Individuals with and Without Down Syndrome. Journal of Managed Care & Specialty Pharmacy. 23(7). 761–770. 6 indexed citations
20.
Pérez, Evans R. Fernández, et al.. (2017). Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-based Cohort Analysis. Annals of the American Thoracic Society. 15(4). 460–469. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sedat Altın Breakdown of academic impact, for papers by Nurdan Köktürk Breakdown of academic impact, for papers by Michael F. Tenholder Breakdown of academic impact, for papers by Kathleen L. Horan Breakdown of academic impact, for papers by Jette Brommann Kornum Breakdown of academic impact, for papers by Irit Krause Breakdown of academic impact, for papers by Valérie Patenaude Breakdown of academic impact, for papers by Mira T. Keddis Breakdown of academic impact, for papers by S. J. Carlan Breakdown of academic impact, for papers by Seok Jeong Lee
Rankless by CCL
2026